QPCT and Alzheimer disease: Within the context of Alzheimer’s disease, the present study identifies tannic acid as a potent inhibitor of human glutaminyl cyclase (hQC), an enzyme critically involved in the formation of neurotoxic pyroglutamate-modified amyloid-β (pE-Aβ3-42).